Adverse event totals12

The totals the trial posted for each group.

1 to 12 of 12

Total	Group	Affected	At risk
Total, all-cause mortality	Abituzumab 250 mg
Total, all-cause mortality	Abituzumab 500 mg
Total, all-cause mortality	Abituzumab 1000 mg
Total, all-cause mortality	Abituzumab 1500 mg
Total, other adverse events	Abituzumab 250 mg	10	10
Total, other adverse events	Abituzumab 500 mg	13	13
Total, other adverse events	Abituzumab 1000 mg	8	8
Total, other adverse events	Abituzumab 1500 mg	10	10
Total, serious adverse events	Abituzumab 250 mg	5	10
Total, serious adverse events	Abituzumab 500 mg	7	13
Total, serious adverse events	Abituzumab 1000 mg	5	8
Total, serious adverse events	Abituzumab 1500 mg	7	10

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00848510/event-totals